The challenge of lipid-modifying therapies in the achievement of optimal LDL-C levels in high and very high CV risk patients: Still an open question

I Rossi,D D'Ardes,B Bucciarelli,F Bianco,F Troiano,P Vizzarri,M Caporale,F Cipollone,M Bucci

doi:10.1016/j.atherosclerosis.2022.06.875

The challenge of lipid-modifying therapies in the achievement of optimal LDL-C levels in high and very high CV risk patients: Still an open question

I Rossi, D D'Ardes + Show 7 more

Open Access

https://doi.org/10.1016/j.atherosclerosis.2022.06.875

Copy DOI

Journal: Atherosclerosis

Publication Date: Aug 1, 2022

Affiliation: University of Chieti-Pescara, Azienda Ospedaliero Universitaria Ospedali Riuniti

#High Cardiovascular Risk Patients #Achievement Of Treatment Targets + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Background and Aims : Hypercholesterolemia is one of the main modifiable atherosclerotic cardiovascular (CV) disease’s risk factors. The aim was to evaluate the efficacy of the currently available lipid lowering therapy (LLT) and the achievement of treatment targets (TT) in a cohort of high and very-high CV risk patients treated with maximum tolerated LLT.

Full Text